chr7-138798172-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001085429.2(TMEM213):c.68C>T(p.Ser23Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000383 in 1,594,578 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001085429.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM213 | NM_001085429.2 | c.68C>T | p.Ser23Leu | missense_variant | 1/3 | ENST00000442682.7 | NP_001078898.1 | |
ATP6V0A4 | NM_020632.3 | c.-259G>A | 5_prime_UTR_variant | 1/22 | ENST00000310018.7 | NP_065683.2 | ||
ATP6V0A4 | NM_130840.3 | c.-156G>A | 5_prime_UTR_variant | 1/21 | NP_570855.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM213 | ENST00000442682.7 | c.68C>T | p.Ser23Leu | missense_variant | 1/3 | 1 | NM_001085429.2 | ENSP00000390407 | P4 | |
ATP6V0A4 | ENST00000310018.7 | c.-259G>A | 5_prime_UTR_variant | 1/22 | 1 | NM_020632.3 | ENSP00000308122 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152124Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000281 AC: 6AN: 213534Hom.: 0 AF XY: 0.0000434 AC XY: 5AN XY: 115124
GnomAD4 exome AF: 0.0000388 AC: 56AN: 1442454Hom.: 0 Cov.: 31 AF XY: 0.0000503 AC XY: 36AN XY: 715458
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152124Hom.: 0 Cov.: 30 AF XY: 0.0000269 AC XY: 2AN XY: 74298
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 03, 2022 | The c.68C>T (p.S23L) alteration is located in exon 1 (coding exon 1) of the TMEM213 gene. This alteration results from a C to T substitution at nucleotide position 68, causing the serine (S) at amino acid position 23 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at